ArticleFrontiers in oncology2025

Combined serine protease PRSS22 and CEA mRNA analysis identifies the majority of colon cancer patients that recur within 12 years.

Alaa Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.